Changes in immunoreactivity of orexin-A-positive neurons after intravenous lipopolysaccharide injection

Medical Science Monitor

Volumn 14, Issue 7, 2008, Pages

  Perekrest, Sofia V ^a   Abramova, Taissia V ^a   Novikova, Nataliya S ^a   Loskutov, Yurii V ^a   Rogers, Vernon J ^b   Korneva, Elena A ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

^b Institute for Bioinforrnation Research   (United States)

Author keywords

Hypothalamus; Lipopolysaccharide; Orexin

Indexed keywords

AVIDIN; BIOTIN; LIPOPOLYSACCHARIDE; OREXIN A; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE CELL; NONHUMAN; PROTEIN LOCALIZATION; RAT; SYNTHESIS;

ANIMALS; HYPOTHALAMIC AREA, LATERAL; INJECTIONS, INTRAVENOUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPOLYSACCHARIDES; MALE; NEURONS; NEUROPEPTIDES; RATS; RATS, WISTAR;

EID: 48349086476     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Beuckmann CT, Yanagisawa M: Orexin: from neuropeptides to energy homeostasis and sleep/wake regulation. J Mol Med, 2002; 80(6): 329-42
2. Espana RA, Baldo BA, Kelley AE, Berridge CW: Wake-promoting and sleep-supressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroccience, 2001; 106(4): 699-715
3. Ida T, Nakahara K, Katayama T et al: Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats. Brain Research, 1999; 821: 526-29
4. Dube MG, Kalra SP, Kalra PS: Food intake elicited by central administration of orexins / hypocretins: identification of hypothalamic sites of action. Brain Research, 1999; 842: 471-77
5. Ida T, Nakahara K, Murakami T et al: Possible involvement, of orexin in the stress reaction in rat. Biochemical and Biophysical Research Communications, 2000; 270: 318-23
6. Watanabe S, Kuwaki T, Yanagisawa M et al: Persistent pain and stress activate pain-inhibitory orexin pathways. Neuroreport, 2005; 16(1): 5-8
7. Swanson LW, Sanchez-Watts G, Watts AG: Comparison of melanin- concentrating hormone and hypocretin/orexin mRNA expression patterns in a new parceling scheme of the lateral hypothalamic zone. Neuroscience Letters, 2005; 387: 80-84
8. Kastin AJ, Akerstrom V: Orexin A but not orexin B rapidly enters brain from blood by simple diffusion. J Pharmacol Exp Ther, 1999; 289: 219-23
9. Peyron C, Tighe DK, van den Pol AN et al: Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neuroscience, 1998; 18(23): 9996-10015
10. Korneva EA, Khai LM: Effects of hypothalamic area lesion on immunogenic process/Vliyaniye razrusheniya uchastkov gipotalamicheskoy oblasti na protses immunogeneza (in Russian). Physiol J. 1963; 49(1): 42-48
11. Lesnikov VA: Neurohumoral mechanisms of regulation of function of bone marow as a source of stem hemopoietic cells [Neirogumoralniye mehamsmi regulacii funkcii krasnogo kostnogo mozga kak istochnika stvolovih gemopoeticheskih kletok (in Russian)]. In: Korneva EA (ed.) Immunophysiology. St. Petersburg: NAUKA; 1993; 294-315
12. Shanin SN, Ryhakina EG, Novikova NN et al: Natural killer cell cytotoxic activity and c-Fos protein synthesis in rat hypothalamic cells after painful electric stimulation of the hind limbs and EHF irradiation of the skin. Med Sci Monit, 2005; 11(9): BR309-15
13. Wenner M, Kawamura M, Ishikawa N: Reward linked to increased natural killer cell activity in rats. NeuroImmunoModulation, 2000; 7: 1-5
14. Hervieu GJ, Cludery JE, Harrison DC et al: Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Nueroscience, 2001; 103: 777-97
15. Trevedi P, Yu H, MacNeil D et al: Distribution of orexin receptor mRNA in the rat brain. FEES Letters. 1998; 438: 71-75
16. Taheri S, Mahmoodi M, Opacka-Juffiry J et al: Distribution and quantification of immunoreactive orexin A in rat tissues. FEBS Letters. 1999; 457: 157-61
17. de Lecea L, Sutcliffe JG: The hypocretins/orexins: Novel hypothalamic neuropeptides involved in different physiological systems. Cell Mol Life Sci, 1999; 56: 473-80
18. Randeva HS, Karteris E, Grammatopoulos D, Hillhouse EW: Expression of orexin-A and functional orexin type 2 receptors in the human adult adrenals: implications for adrenal function and energy homeostasis. J. Clin Endocrinol Metabolism. 2001; 86(10): 4808-13
19. Zhang S, Blache D, Vercoe PE et al: Expression of orexin receptors in the brain and peripheral tissues of the male sheep. Regul Pept, 2005; 124(91-43): 81-87
20. + hematopoietic stem and progenitor cells express functionally active receptors of neuromediators. Blood, 2004, 104(1): 81-88
21. Wrona D, Trojniar W: Chronic electrical stimulation of the lateral hypothalamus increases natural Killer cell cytotoxicity in rats. J Neuroimmunol, 2003; 141: 20-29
22. Cano G, Sved AF, Rinamen L et al: Characterization of the central nervous system innervation of the rat spleen using viral trasneuronal tracing. J Comp Neurol, 2001; 439: 1-18
23. Denes A, Boldogkoi Z, Uhereczky G et al: Central autonomic control of the bone marrow: Multisynaptic tract tracing by recombinant pseudorabies virus. Neuroscience, 2005; 25: 1-17
24. Perekrest SV, Gavrilov YuV, Abramova TV et al: Activation of cells in hypothalamic structures after injections of antigens of different nature (by c-fos gene expression) [Aktivaciya kletok gipotalamicheskih struktur pri vvedenii antigenov razlichnoy prirody (po ekspressii c-fos gena) (in Russian)]. Med Immunol. 2006; 8(5-6): 631-36
25. Gavrilov YV, Perekrest SV, Novikova NS, Korneva EA: Effects of electric pain stimulation on the activation level of cells in hypothalamic structures, induced by injection of different antigens [Effekty deystviya elektrobolevogo razdrazheniya na intensivnost' aktivacii kletok gipotalamicheskih struktur, inducirovannoy vvedeniem razlichnyh antigenov (in Russian)]. Physiol and Pathol of Immun Syst, 2006; 7: 17-26
26. Elmquist JK, Scammell TE, Jacobson CD, Saper CB: Distribution of Fos-like immunoreactivity in the rat brain following intravenous lipopolysaccharide administration. J of Comp Neurol, 1996; 371(1): 85-103
27. Zhang Y-H, Jan Lu JK, Elmquist JK, Saper CB: Lipopolysaccharide activates specific populations of hypothalamic and brainstem neurons that project of the spinal cord. J of Neuroscience, 2000; 20(17): 6578-86
28. Gaykema RPA Goehlar LE, Armstrong CB et al: Differential FOS expression rat brain induced by lipopolisaccharide and staphylococcal enterotoxin B. Neuroimmunomodulation, 1999; 6: 220
29. Korneva EA, Kazakova TB, Nosov MA: Expression of c-fos mRNA and c-Fos-like proteins in cells of hypothalamic structures after antigen injection [Ekspressiya c-fos mRNK i c-Fos-podobnih belkov v kletkah gipotalamicheskih structur pri vvedenii antigena (in Russian)]. Allergol and Immunol. 2001; (1): 37-44
30. Gaykema RPA, Goehler LE, Bol FJH et al: Bacterial endotoxin induces For immunoreactivity in primary afferent neurons of the vagus nerve. Neuroimmunomodulation, 1998; 5: 234-40
31. Goehler LE, Ron PA, Gaykema K et al: Staphylococcal enterotoxin B induces fever, brain c-Fos expression, and serum corticosterone in rats. Am J Physiol Regulatory Integrative Comp Physiol, 2001; 280: R1434-39
32. Taheri S, Sunter D, Dakin C et al. Diurnal variation in orexin A immunoreactivity and prepro-orexin mRNA in the rat central nervous system. Neuroscience Letters, 2000; 279: 109-12
33. rd rev ed. San-Diego, Cal. USA Elsevier acad press; 2004
34. Webel DM Finck BN, Baker DH, Johnson RW: Time Course of Increased Plasma Cytokines, Cortisol, and Urea Nitrogen in Pigs Following Intraperitoneal Injection of Lipopolysaccharide. J Anim Sci. 1997; 75: 1514-20
35. Hopkins Sf, Rothwell NJ: Cytokines and the nervous system I: expression and regulation. Trends Neurosci, 1995; 18: 83-88
36. Turnbull AV, Rivier CL: Regulation of the Hypothalamic-Pitiutary-Adrenal Axis by Cytokines: Actions and Mechanisms of Action. Physiological Reviews, 1999; 79(1): 1-71
37. Ferguson AV, Samson WK: The orexin/hypocretin system: A critical regulator of neuroendocrine and autonomic function. Frontiers in Neuroendocnnology, 2002; 24: 141-50
38. Sakurai Z, Nishyima T, Takahashi S et al: Low plasma orexin-A levels were improved by continuous positive airway pressure treatment in patients with severe obstructive sleep apnea-hypopnea syndrome. Chest, 2005; 127: 731-37